Clinical Trial Update: Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bendamustine in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Robert Redner, MD | Conditions: Myeloma | Phase 1 | Status: COMPLETED